Carsten Reinhardt

Carsten Reinhardt currently works at Revitope Oncology, Inc., as Director from 2020, Theolytics Ltd., as Non-Executive Director from 2020, Immatics Biotechnologies GmbH, as Chief Development Officer from 2020, American Society of Clinical Oncology, Inc., as Member, American Society of Hematology, as Member, European Society for Medical Oncology, as Member, Association For Cancer Immunotherapy, as Member, Immatics US, Inc., as Chief Medical Officer, and Immatics NV, as Chief Development Officer from 2020.
Dr. Reinhardt also formerly worked at Automotive Axles Ltd., as Director, Freightliner Corp., as Director-Manufacturing Engineering, F.
Hoffmann-La Roche Ltd., as Head-International Medicine from 1994 to 1996, Micromet AG, as SVP-Clinical Development from 2005 to 2009, Amgen Rockville, Inc., as Chief Medical Officer & Senior Vice President from 2006 to 2009, and Neovii Biotech GmbH, as Head-Clinical Development from 2000 to 2003.
Dr. Reinhardt received his doctorate degree in 1994 from Ludwig-Maximilians-Universität München and undergraduate degree in 1993 from Ludwig-Maximilians-Universität München.